A new electronic pill is being touted as the new answer to tackling obesity and helping weight loss thanks to its revolutionary design.
The pill has been formulated to trick the brain into effectively thinking that the stomach is full and is said to work in the same way as a gastric pacemaker which helps to surpress the appetite and to stop people from over eating.
According to a report by the Daily Mail, a gastric pacemaker is an implant that is surgically placed in the stomach and wired to the vagus nerve. This nerve carries signals from the stomach to the hypothalamus, the area of the brain responsible for regulating appetite and the pacemaker has a sensor that detects when food is entering the stomach.
The electronic diet pill has been developed by the Israeli firm MelCap Systems and does not need any form of surgery to make it work as instead it is simply swallowed with water.
It is still not known just how much thee pills will cost but it is believed that they will be considerably cheaper than the gastric pacemakers which cost about £10,000.
When a person swallows the electronic pill it can then be externally controlled using a mobile phone app.
As the pill reaches the stomach the app is used to trigger the release of a mesh which then stops the pill from passing into the bowel and keeps it in the stomach.
To get the pill into the right position a magnet is used and then the pill begins to work its high tech magic, sensing muscle contractions that tell the stomach when food is coming and then sending out a signal to tell the brain to reduce the level of appetite to help stop over eating.
After three or four weeks the pill breaks down and eaves the body naturally after hopefully encouraging weight loss without the need for surgery.
Tam Fry, of the National Obesity Forum, said to the Daily Mail: ‘This technology is going in the right direction.
‘But we don’t know the cost and the NHS is getting very tough on price, even when medication is known to be effective.’
The electronic diet pill may be the future of weight loss but unless it can be used within national health systems or it can come down in price ten it will remain a tool only for the very wealthy.